Predictors of mortality and adverse events in patients with infective endocarditis: a retrospective real world study in a surgical centre

被引:33
作者
Scheggi, Valentina [1 ,2 ]
Merilli, Irene [1 ,2 ]
Marcucci, Rossella [2 ,3 ]
Del Pace, Stefano [2 ,3 ]
Olivotto, Iacopo [2 ,3 ]
Zoppetti, Nicola [5 ]
Ceschia, Nicole [2 ,3 ]
Andrei, Valentina [2 ,3 ]
Alterini, Bruno [1 ,2 ]
Stefano, Pier Luigi [2 ,4 ]
Marchionni, Niccolo [2 ,3 ]
机构
[1] Azienda Osped Univ Careggi, Div Cardiovasc & Perioperat Med, Cardiothoracovasc Dept, Largo Brambilla 3, I-50143 Florence, Italy
[2] Univ Florence, Largo Brambilla 3, I-50143 Florence, Italy
[3] Azienda Osped Univ Careggi, Div Gen Cardiol, Cardiothoracovasc Dept, Florence, Italy
[4] Azienda Osped Univ Careggi, Div Cardiac Surg, Cardiothoracovasc Dept, Florence, Italy
[5] CNR, Inst Appl Phys Nello Carrara IFAC, Sesto Fiorentino, Italy
关键词
Infective endocarditis; Prognostic factors; Outcome; Valvular dysfunction; Endocarditis; Mortality; Prognosis; CHALLENGES;
D O I
10.1186/s12872-021-01853-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Mortality in infective endocarditis (IE) is still high, and the long term prognosis remains uncertain. This study aimed to identify predictors of long-term mortality for any cause, adverse event rate, relapse rate, valvular and ventricular dysfunction at follow-up, in a real-world surgical centre. Methods We retrospectively analyzed 363 consecutive episodes of IE (123 women, 34%) admitted to our department with a definite diagnosis of non-device-related IE. Median follow-up duration was 2.9 years. Primary endpoints were predictors of mortality, recurrent endocarditis, and major non-fatal adverse events (hospitalization for any cardiovascular cause, pace-maker implantation, new onset of atrial fibrillation, sternal dehiscence), and ventricular and valvular dysfunction at follow-up. Results Multivariate analysis independent predictors of mortality showed age (HR per unit 1.031, p < 0.003), drug abuse (HR 3.5, p < 0.002), EUROSCORE II (HR per unit 1.017, p < 0.0006) and double valve infection (HR 2.3, p < 0.001) to be independent predictors of mortality, while streptococcal infection remained associated with a better prognosis (HR 0.5, p < 0.04). Major non-fatal adverse events were associated with age (HR 1.4, p < 0.022). New episodes of infection were correlated with S aureus infection (HR 4.8, p < 0.001), right-sided endocarditis (HR 7.4, p < 0.001), spondylodiscitis (HR 6.8, p < 0.004) and intravenous drug abuse (HR 10.3, p < 0.001). After multivariate analysis, only drug abuse was an independent predictor of new episodes of endocarditis (HR 8.5, p < 0.001). Echocardiographic follow-up, available in 95 cases, showed a worsening of left ventricular systolic function (p < 0.007); severe valvular dysfunction at follow-up was reported only in 4 patients, all of them had mitral IE (p < 0.03). Conclusions The present study highlights some clinical, readily available factors that can be useful to stratify the prognosis of patients with IE.
引用
收藏
页数:9
相关论文
共 31 条
[1]   Comparison of prognoses of Staphylococcus aureus left-sided prosthetic endocarditis and prosthetic endocarditis caused by other pathogens [J].
Abdallah, Layal ;
Habib, Gilbert ;
Remadi, Jean-Paul ;
Salaun, Erwan ;
Casalta, Jean-Paul ;
Tribouilloy, Christophe .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2016, 109 (10) :542-549
[2]   Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study [J].
Agrawal, Akanksha ;
Virk, Hafeez Ul Hassan ;
Riaz, Iqra ;
Jain, Deepanshu ;
Tripathi, Byomesh ;
Krittanawong, Chayakrit ;
Bozorgnia, Benham ;
Figueredo, Vincent ;
McCullough, Peter A. ;
Rangaswami, Janani .
REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (01) :123-127
[3]   Infective endocarditis and diabetes mellitus: Results from a single-center study from 1994 to 2017 [J].
Benvenga, Rossella M. ;
De Rosa, Roberta ;
Silverio, Angelo ;
Matturro, Rosanna ;
Zambrano, Cristina ;
Masullo, Alfonso ;
Mastrogiovanni, Generoso ;
Soriente, Lucia ;
Ascoli, Roberto ;
Citro, Rodolfo ;
Piscione, Federico ;
Galasso, Gennaro .
PLOS ONE, 2019, 14 (11)
[4]   Challenges in Infective Endocarditis [J].
Cahill, Thomas J. ;
Baddour, Larry M. ;
Habib, Gilbert ;
Hoen, Bruno ;
Salaun, Erwan ;
Pettersson, Gosta B. ;
Schaefers, Hans Joachim ;
Prendergast, Bernard D. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (03) :325-344
[5]   Infective endocarditis [J].
Cahill, Thomas J. ;
Prendergast, Bernard D. .
LANCET, 2016, 387 (10021) :882-893
[6]   Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study [J].
Chirouze, C. ;
Athan, E. ;
Alla, F. ;
Chu, V. H. ;
Corey, G. Ralph ;
Selton-Suty, C. ;
Erpelding, M-L ;
Miro, J. M. ;
Olaison, L. ;
Hoen, B. .
CLINICAL MICROBIOLOGY AND INFECTION, 2013, 19 (12) :1140-1147
[7]   Inflammatory parameters and prediction of prognosis in infective endocarditis [J].
Cornelissen, Christian G. ;
Frechen, Dirk A. ;
Schreiner, Karin ;
Marx, Nikolaus ;
Krueger, Stefan .
BMC INFECTIOUS DISEASES, 2013, 13
[8]   RECONSTRUCTION OF THE MITRAL ANULUS - A 10-YEAR EXPERIENCE [J].
DAVID, TE ;
FEINDEL, CM ;
ARMSTRONG, S ;
SUN, Z .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 110 (05) :1323-1332
[9]   Infective endocarditis in intravenous drug users from Italy: The increasing importance in HIV-infected patients [J].
De Rosa, F. G. ;
Cicalini, S. ;
Canta, F. ;
Audagnotto, S. ;
Cecchi, E. ;
Di Perri, G. .
INFECTION, 2007, 35 (03) :154-160
[10]  
Delamaire M, 1997, DIABETIC MED, V14, P29, DOI 10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO